Name | 3,5,3',5'-Tetraiodo Thyroacetic Acid |
Synonyms | tetraiodothyroaceticacid Liothyronine EP Impurity D Levothyroxine – Impurity D 3,3',5,5'-tetraiodo-thyroaceticaci 3,5,3',5'-Tetraiodo Thyroacetic Acid acide3,5,3',5'-tetraiodothyroacetique 3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneaceticacid 3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)-benzeneaceticaci 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid |
CAS | 67-30-1 |
EINECS | 200-649-1 |
InChIKey | PPJYSSNKSXAVDB-UHFFFAOYSA-N |
Molecular Formula | C14H8I4O4 |
Molar Mass | 747.83 |
Density | 2.727±0.06 g/cm3(Predicted) |
Melting Point | 219-220 °C (decomp) |
Boling Point | 544.8±50.0 °C(Predicted) |
Solubility | acetone: soluble19.60 - 20.40mg/mL, clear, colorless (or faintly yellow to yellow) |
Appearance | powder to crystal |
Color | White to Yellow to Green |
pKa | 3.98±0.10(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
MDL | MFCD00055932 |
Hazard Symbols | T+ - Very toxic |
Risk Codes | 28 - Very Toxic if swallowed |
Safety Description | 45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | UN 2811 6.1/PG 1 |
WGK Germany | 3 |
RTECS | CY1585800 |
Biological activity | Tetrac (Tetraiodothyroacetic acid), a natural derivative of L-thyroxine (T4), is a thyroxine integrin receptor antagonist. Tetrac blocks the action of T4 and 3,5,3 '-triiodo-L-thyronine (T3) at the cell surface receptor of thyroid hormone on integrin αvβ3. Tetra has anti-angiogenic and anti-tumor activities. |
Cell Line: | HT-29 and HCT116 cells HT-29 and HCT116 cells |
Concentration: | 0.01, 0.1, 1 μM 0.1 μM |
Incubation Time: | 0, 2, 4, 6 days 30 min |
Result: | Induced anti-proliferation of K-RAS wild-type colorectal cancer cells. Inhibited constitutively activated ERK1/2, and this inhibition can remove by anti-integrin αvβ3 antibody pretreatment. Delayed the onset of ocular melanoma. Reduced the S-100 and integrin staining level in the B16F10 mice model. |
Animal Model: | Wild-type male Balb/C mice aged 8 weeks are inoculated with 102B16F10 or B16LS9 cells |
Dosage: | 35 μg per day |
Administration: | P.o. (added to the drinking water) daily for 40 days |